Literature DB >> 23917847

Stroke: Is thrombolysis safe in anticoagulated ischaemic stroke?

Roland Veltkamp, Timolaos Rizos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23917847     DOI： 10.1038/nrneurol.2013.159

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  10 in total

1.  Risks of intracranial hemorrhage among patients with acute ischemic stroke receiving warfarin and treated with intravenous tissue plasminogen activator.

Authors:  Ying Xian; Li Liang; Eric E Smith; Lee H Schwamm; Mathew J Reeves; DaiWai M Olson; Adrian F Hernandez; Gregg C Fonarow; Eric D Peterson
Journal:  JAMA       Date:  2012-06-27       Impact factor: 56.272

2.  Safety of intravenous thrombolysis for ischemic stroke in patients treated with warfarin.

Authors:  Michael V Mazya; Kennedy R Lees; Romesh Markus; Risto O Roine; Raymond C S Seet; Nils Wahlgren; Niaz Ahmed
Journal:  Ann Neurol       Date:  2013-09-04       Impact factor: 10.422

3.  Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists.

Authors:  Harold P Adams; Gregory del Zoppo; Mark J Alberts; Deepak L Bhatt; Lawrence Brass; Anthony Furlan; Robert L Grubb; Randall T Higashida; Edward C Jauch; Chelsea Kidwell; Patrick D Lyden; Lewis B Morgenstern; Adnan I Qureshi; Robert H Rosenwasser; Phillip A Scott; Eelco F M Wijdicks
Journal:  Stroke       Date:  2007-04-12       Impact factor: 7.914

4.  Oral anticoagulants--a frequent challenge for the emergency management of acute ischemic stroke.

Authors:  Timolaos Rizos; Solveig Horstmann; Ekkehart Jenetzky; Marcia Spindler; Christoph Gumbinger; Markus Möhlenbruch; Peter Ringleb; Werner Hacke; Roland Veltkamp
Journal:  Cerebrovasc Dis       Date:  2012-12-05       Impact factor: 2.762

5.  Anticoagulation with dabigatran does not increase secondary intracerebral haemorrhage after thrombolysis in experimental cerebral ischaemia.

Authors:  Li Sun; Wei Zhou; Robert Ploen; Markus Zorn; Roland Veltkamp
Journal:  Thromb Haemost       Date:  2013-04-25       Impact factor: 5.249

6.  Point-of-care international normalized ratio testing accelerates thrombolysis in patients with acute ischemic stroke using oral anticoagulants.

Authors:  Timolaos Rizos; Christian Herweh; Ekkehart Jenetzky; Christoph Lichy; Peter Arthur Ringleb; Werner Hacke; Roland Veltkamp
Journal:  Stroke       Date:  2009-08-20       Impact factor: 7.914

7.  Guidelines for management of ischaemic stroke and transient ischaemic attack 2008.

Authors: 
Journal:  Cerebrovasc Dis       Date:  2008-05-06       Impact factor: 2.762

8.  Thrombolysis in stroke despite contraindications or warnings?

Authors:  Benedikt Frank; James C Grotta; Andrei V Alexandrov; Erich Bluhmki; Patrick Lyden; Atte Meretoja; Nishant K Mishra; Ashfaq Shuaib; Nils G Wahlgren; Christian Weimar; Kennedy R Lees
Journal:  Stroke       Date:  2013-02-06       Impact factor: 7.914

Review 9.  Treatment of acute ischaemic stroke with thrombolysis or thrombectomy in patients receiving anti-thrombotic treatment.

Authors:  Hans-Christoph Diener; Christian Foerch; Hanno Riess; Joachim Röther; Gerhard Schroth; Ralph Weber
Journal:  Lancet Neurol       Date:  2013-05-31       Impact factor: 44.182

10.  Potentially preventable strokes in high-risk patients with atrial fibrillation who are not adequately anticoagulated.

Authors:  David J Gladstone; Esther Bui; Jiming Fang; Andreas Laupacis; M Patrice Lindsay; Jack V Tu; Frank L Silver; Moira K Kapral
Journal:  Stroke       Date:  2008-08-28       Impact factor: 7.914
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.